Renal Allograft Tolerance Through Mixed Chimerism

Completed · Phase 1/Phase 2

Conditions studied: End Stage Renal Disease

In brief

This study will examine the safety and effectiveness of a combination kidney and bone marrow transplant from a haplo-identical related donor. An investigational medication and other treatments will be given prior to and after the transplant to help protect the transplanted kidney from being attacked by the body's immune system

Key facts

Study ID
NCT01780454
Run by
Massachusetts General Hospital
People needed
2
Starts
2013-03-01
Expected to finish
2020-06-01
Last updated by the study team
2021-04-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.